Asb Consultores, LLC Merck & Co., Inc. Transaction History

Asb Consultores, LLC

$249 Million
Q3 2024

A detailed history of Asb Consultores, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Asb Consultores, LLC holds 1,905 shares of MRK stock, worth $190,614. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,905

Previous 3,888 51.0%

Holding current value

$190,614

Previous $481,000 55.09%

% of portfolio

0.09%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$111.15 - $128.97 $220,410 - $255,747	-1,983 Reduced 51.0%	1,905 $216,000
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $199,565 - $214,331	-1,612 Reduced 29.31%	3,888 $481,000
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $411,627 - $479,638	3,635 Added 194.91%	5,500 $725,000
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $162,091 - $176,394	-1,618 Reduced 46.45%	1,865 $203,000
Q3 2023 Nov 28, 2023	SELL	$102.95 - $114.33 $377,929 - $419,705	-3,671 Reduced 51.31%	3,483 $358,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $34,320 - $37,408	-316 Reduced 4.23%	7,154 $825,000
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $62,381 - $69,605	-606 Reduced 7.5%	7,470 $794,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $117,169 - $150,227	-1,340 Reduced 14.23%	8,076 $895,000
Q3 2022 Jan 11, 2023	BUY	$84.53 - $94.96 $137,276 - $154,215	1,624 Added 20.84%	9,416 $811,000
Q2 2022 Jan 11, 2023	SELL	$83.49 - $94.64 $195,700 - $221,836	-2,344 Reduced 23.13%	7,792 $710,000
Q1 2022 Jan 11, 2023	BUY	$73.51 - $82.4 $745,097 - $835,206	10,136 New	10,136 $832,000
Q4 2021 Jan 11, 2023	BUY	$72.28 - $90.54 $52,041 - $65,188	720 Added 7.65%	10,136 $777,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.

Account

Asb Consultores, LLC Merck & Co., Inc. Transaction History